Literature DB >> 21353133

Long-term maintenance lorazepam for catatonia: a case report.

Sandeep Grover1, Munish Aggarwal.   

Abstract

Catatonia is described as a syndrome of motor abnormality associated with the disorder of thought, behavior and emotions. Lorazepam has been shown to be useful in the short-term management of catatonia [Ungvari G.S., Kau L.S., Wai-Kwong T., Shing N.F., The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001;251(suppl 1):31-34; Daniels J., Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009;21:371-380]. However, there is sparse literature with respect to patients requiring long-term maintenance lorazepam for catatonia. Manjunatha et al. [Manjunatha N., Saddichha S., Khess C.R.J., Idiopathic recurrent catatonia needs maintenance lorazepam: case report and review. Aust NZ J Psychiatry 2007;41:625-627] described a case which required long-term maintenance lorazepam for recurrent catatonia that was unresponsive to most antipsychotics. Gaind et al. [Gaind G.S., Rosebush P.I., Mazurek M.F., Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry 1994;55:20-23] described the use of maintenance lorazepam in a mentally retarded boy with catatonia of 5 years' duration, which improved slowly over a period of 5 months. We present a case of recurrent catatonia, in which symptoms relapsed whenever an attempt was made to taper off lorazepam.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21353133     DOI: 10.1016/j.genhosppsych.2010.06.006

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  6 in total

1.  Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.

Authors:  Hadar Zaman; Roger Carl Gibson; Geoffrey Walcott
Journal:  Cochrane Database Syst Rev       Date:  2019-08-05

Review 2.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

Review 3.  Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology.

Authors:  Sean A Rasmussen; Michael F Mazurek; Patricia I Rosebush
Journal:  World J Psychiatry       Date:  2016-12-22

4.  Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.

Authors:  Kazutaka Ohi; Aki Kuwata; Takamitsu Shimada; Toshiki Yasuyama; Yusuke Nitta; Takashi Uehara; Yasuhiro Kawasaki
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Chronic catatonia treated with electroconvulsive therapy: a case report.

Authors:  Varuni A de Silva; Wickramaarachchige D Lakmini; Heshan N Gunawardena; Raveen Hanwella
Journal:  J Med Case Rep       Date:  2013-08-23

6.  Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.

Authors:  Chin-Chuen Lin; Yi-Yung Hung; Meng-Chang Tsai; Tiao-Lai Huang
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.